Guest Column: India Farm Bills 2020- Return to the Days of Champaran Struggle  |  Guest Column: Before Covid, After Covid  |  Guest Column: India Should Give Martyrdom Status to Covid Warriors  |  International Edu News: New Antibiotic against Drug-Resistant Bacteria  |  National Edu News: Webinar on “Faculty Development for Quality Education”  |  Science Innovations: Scientists find a new model to probe how black holes rip apart starts  |  Leadership Instincts: The NEP to make India a 'knowledge power'- Education Minister  |  International Edu News: Timely Financial Help for NTU Singapore Students  |  Leadership Instincts: Innovation = Ideas + Implementation  |  Education Information: Several schemes to encourage students towards the field of science & technology  |  Leadership Instincts: First ever AICTE - Visvesvaraya Best Teachers Award 2020  |  National Edu News: Digital India Corporation observes Engineer’s Day  |  Education Information: The NCERT eight-week alternative academic calendar for the secondary stage   |  Leadership Instincts: 16,99,931 School Heads and Teachers got training under NISHTHA in 2019-20  |  Leadership Instincts: Ministry of Education ensures Quality Education to students across the country  |  
May 21, 2020 Thursday 09:12:05 PM IST

RNA extraction kit Agappe Chitra Magna launched commercially

National Edu News

Dr VK Saraswat, NITI Aayog member and President of Institute body of Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST)announed here today the commercial launch of Agappe Chitra Magna, a magnetic nanoparticle-based RNA extraction kit for use during testing for detection of COVID-19. The announcement was made by Dr VK Saraswat, at a programme attended by Prof. Ashutosh Sharma, Secretary, DST, Dr Asha Kishore, Director SCTIMST, Dr HK Varma, Head Biomedical technology and scientists of the institute, through a video conference.

The RNA extraction kit was developed by Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum, an Institute of National Importance of the Department of Science and Technology (DST) along with Agappe Diagnostics Ltd, an in vitro diagnostics manufacturing company based in Cochin.  The launch programme was organized by SCTIMST in collaboration with Agappe Diagnostics Ltd at the Biomedical Technology Wing of SCTIMST, and it was followed by the first sale of the product by Mr. Thomas John, Managing Director, Agappe Diagnostics, to officials from Amrita Institute of Medical Sciences, Kochi.

Inexpensive, fast, and accurate testing for COVID-19 virus is the cornerstone of containing its spread and providing appropriate help to the infected. The Chitra Magna, an innovative RNA extraction kit developed by SCTIMST under the leadership of senior scientist, Dr. Anoop kumarThekkuveettil, was transferred to Agappe Diagnostics in April 2020, and will now be available in the market as Agappe Chitra Magna RNA Isolation Kit. This product has been independently validated at National Institute of Virology for Covid19 RNA isolation. Central Drugs Standard Control Organisation (CDSCO) has given approval for the commercialization of this kit. The kit can be used for RNA extraction for RT-LAMP, RT-qPCR, RT-PCR and other isothermal and PCR based protocols for the detection of SARS-COV-2.

It uses an innovative technology for isolating RNA using magnetic nanoparticles to capture the RNA from the patient sample. The magnetic nanoparticle beads bind to the viral RNA and, when exposed to a magnetic field, give a highly purified and concentrated RNA. As the sensitivity of the detection method is dependent on getting an adequate quantity of viral RNA, this innovation enhances the chances of identifying positive cases.


It is estimated that India would require about 8 lakh RNA extraction kits per month during the next six months, and Agappe Chitra Magna RNA Isolation Kit priced around Rs. 150 per kit is expected to reduce the cost of testing and the country’s dependence on imported kits which cost around Rs 300. Agappe Diagnostics has a manufacturing capacity of kits for performing 3Lkah kits per month. 

Comments